These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 25056381

  • 21. Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.
    Saracco MG, Allais G, Tullo V, Zava D, Pezzola D, Reggiardo G, Omboni S, Benedetto C, Bussone G, Aguggia M.
    Neurol Sci; 2014 May; 35 Suppl 1():115-9. PubMed ID: 24867847
    [Abstract] [Full Text] [Related]

  • 22. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 23. Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial.
    Allais G, Bussone G, Tullo V, Cortelli P, Valguarnera F, Barbanti P, Sette G, D'Onofrio F, Curone M, Benedetto C.
    Cephalalgia; 2015 Jan; 35(1):45-50. PubMed ID: 25053749
    [Abstract] [Full Text] [Related]

  • 24. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD, Elkind AH, Schreiber C, Keywood C.
    Neurology; 2004 Jul 27; 63(2):261-9. PubMed ID: 15277618
    [Abstract] [Full Text] [Related]

  • 25. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K, Mills EJ, Wu P, Ramos E, Chatterjee A, Druyts E, Goadsby PJ.
    Cephalalgia; 2014 Apr 27; 34(4):258-67. PubMed ID: 24108308
    [Abstract] [Full Text] [Related]

  • 26. Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans.
    Franconi F, Finocchi C, Allais G, Omboni S, Tullo V, Campesi I, Reggiardo G, Benedetto C, Bussone G.
    Neurol Sci; 2014 May 27; 35 Suppl 1(Suppl 1):99-105. PubMed ID: 24867845
    [Abstract] [Full Text] [Related]

  • 27. The evolving management of migraine.
    Ashkenazi A, Silberstein SD.
    Curr Opin Neurol; 2003 Jun 27; 16(3):341-5. PubMed ID: 12858071
    [Abstract] [Full Text] [Related]

  • 28. Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline.
    Kelman L, Harper SQ, Hu X, Campbell JC.
    Curr Med Res Opin; 2010 Sep 27; 26(9):2097-104. PubMed ID: 20642390
    [Abstract] [Full Text] [Related]

  • 29. [Frovatriptan possibly causing acute myocardial infarction].
    Møller-Helgestad OK, Kaltoft AK, Kasch H.
    Ugeskr Laeger; 2015 Mar 23; 177(13):V10140537. PubMed ID: 25822816
    [Abstract] [Full Text] [Related]

  • 30. Factors associated with frovatriptan response in patients with migraine: A prospective, observational study.
    Seo JG, Park SP.
    Cephalalgia; 2016 Apr 23; 36(5):493-8. PubMed ID: 26170008
    [Abstract] [Full Text] [Related]

  • 31. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A, Ryan R, Goldstein J, Keywood C.
    Headache; 2002 Apr 23; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [Abstract] [Full Text] [Related]

  • 32. Frovatriptan.
    Easthope SE, Goa KL.
    CNS Drugs; 2001 Apr 23; 15(12):969-76; discussion 977-8. PubMed ID: 11735616
    [Abstract] [Full Text] [Related]

  • 33. A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.
    Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.
    J Headache Pain; 2011 Apr 23; 12(2):219-26. PubMed ID: 20686810
    [Abstract] [Full Text] [Related]

  • 34. Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.
    Allais G, Tullo V, Omboni S, Pezzola D, Zava D, Benedetto C, Bussone G.
    Neurol Sci; 2013 May 23; 34 Suppl 1(Suppl 1):S83-6. PubMed ID: 23695052
    [Abstract] [Full Text] [Related]

  • 35. Intravenous dexketoprofen vs placebo for migraine attack in the emergency department: A randomized, placebo-controlled trial.
    Gungor F, Akyol KC, Kesapli M, Celik A, Karaca A, Bozdemir MN, Eken C.
    Cephalalgia; 2016 Feb 23; 36(2):179-84. PubMed ID: 25944813
    [Abstract] [Full Text] [Related]

  • 36. Acute migraine therapy: recent evidence from randomized comparative trials.
    Mett A, Tfelt-Hansen P.
    Curr Opin Neurol; 2008 Jun 23; 21(3):331-7. PubMed ID: 18451718
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A, Gennings C, Cady R.
    Headache; 2012 Apr 23; 52(4):636-47. PubMed ID: 22221151
    [Abstract] [Full Text] [Related]

  • 38. Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
    Deleu D, Hanssens Y.
    J Clin Pharmacol; 2000 Jul 23; 40(7):687-700. PubMed ID: 10883409
    [Abstract] [Full Text] [Related]

  • 39. Dexketoprofen trometamol in the acute treatment of migraine attack: a phase II, randomized, double-blind, crossover, placebo-controlled, dose optimization study.
    Mainardi F, Maggioni F, Pezzola D, Zava D, Zanchin G.
    J Pain; 2014 Apr 23; 15(4):388-94. PubMed ID: 24412801
    [Abstract] [Full Text] [Related]

  • 40. Acute management of migraine.
    Chowdhury D.
    J Assoc Physicians India; 2010 Apr 23; 58 Suppl():21-5. PubMed ID: 21049703
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.